4.7 Review

Vaccine applications of flow cytometry

Journal

METHODS
Volume 57, Issue 3, Pages 383-391

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ymeth.2012.01.001

Keywords

Flow cytometry; Vaccine; T cell; Immunogenicity; Intracellular cytokine staining

Funding

  1. HIV Vaccine Trials Network Laboratory Program, a cooperative agreement with the National Institutes of Health Division of AIDS (National Institute of Allergy and Infectious Diseases) [UM1 AI068618]
  2. University of Washington Center for AIDS Research, a National Institutes of Health [P30 AI027757]

Ask authors/readers for more resources

Highly effective vaccines have yet to be identified for many widespread infectious diseases including HIV, tuberculosis and malaria. Many vaccine candidates for these diseases have been designed to induce both cellular and humoral immunity, and measurement of the induced cellular immune response and antibody response is critical for monitoring immunogenicity. The flow cytometric intracellular cytokine staining assay is one of the primary assays for enumerating vaccine-induced T cells in vaccine clinical trials. The assay is flexible, allowing for measurement of various cytokines or functions and phenotyping markers, and the assay can be validated. Changes in other cell types such as innate immune cells are monitored by flow cytometric phenotyping assays. Cell sorting of vaccine-induced T cells and B cells is used to allow genomic and transcriptional analysis of these cells. Thus, flow cytometric methods are commonly used in trials testing the next generation of vaccines. (C) 2012 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available